Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1968 1
1970 1
1974 3
1975 12
1976 2
1986 1
1987 3
1988 2
1989 3
1990 3
1991 2
1992 2
1993 2
1994 1
1996 1
1998 2
1999 1
2000 1
2001 2
2002 1
2003 4
2004 5
2005 9
2006 5
2007 8
2008 4
2009 4
2010 5
2011 4
2012 7
2013 3
2014 4
2015 3
2016 3
2018 1
2019 3
2020 2
2021 1
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

116 results

Results by year

Filters applied: . Clear all
Page 1
Optimization and characterization of a carbamate inhibitor for plasma platelet-activating factor acetylhydrolase (pPAFAH).
Nagano JMG, Hsu KL, Speers AE, Brown SJ, Spicer T, Fernandez-Vega V, Ferguson J, Bahnson BJ, Cravatt BF, Hodder P, Rosen H. Nagano JMG, et al. 2011 Nov 30 [updated 2014 May 13]. In: Probe Reports from the NIH Molecular Libraries Program [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2010–. 2011 Nov 30 [updated 2014 May 13]. In: Probe Reports from the NIH Molecular Libraries Program [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2010–. PMID: 23658952 Free Books & Documents. Review.
Changes in ALBI Score and PIVKA-II within Three Months after Commencing Atezolizumab Plus Bevacizumab Treatment Affect Overall Survival in Patients with Unresectable Hepatocellular Carcinoma.
Unome S, Imai K, Takai K, Miwa T, Hanai T, Nishigaki Y, Hayashi H, Kochi T, Shimizu S, Nagano J, Iritani S, Suetsugu A, Shimizu M. Unome S, et al. Among authors: nagano j. Cancers (Basel). 2022 Dec 10;14(24):6089. doi: 10.3390/cancers14246089. Cancers (Basel). 2022. PMID: 36551574 Free PMC article.
Cell-free and concentrated ascites reinfusion therapy versus large-volume paracentesis for the treatment of cirrhotic patients with refractory ascites: A multicenter prospective observational study.
Hanai T, Kawaratani H, Nagano J, Suii H, Sakamaki A, Arase Y, Nakanishi H, Kogiso T, Okubo T, Miwa T, Shimizu S, Hige S, Atsukawa M, Shimizu M, Kurosaki M, Terai S, Kagawa T, Tokushige K, Yoshiji H. Hanai T, et al. Among authors: nagano j. Hepatol Res. 2023 Mar;53(3):238-246. doi: 10.1111/hepr.13860. Epub 2022 Dec 3. Hepatol Res. 2023. PMID: 36433862
Selective inhibitors and tailored activity probes for lipoprotein-associated phospholipase A(2).
Nagano JM, Hsu KL, Whitby LR, Niphakis MJ, Speers AE, Brown SJ, Spicer T, Fernandez-Vega V, Ferguson J, Hodder P, Srinivasan P, Gonzalez TD, Rosen H, Bahnson BJ, Cravatt BF. Nagano JM, et al. Bioorg Med Chem Lett. 2013 Feb 1;23(3):839-43. doi: 10.1016/j.bmcl.2012.11.061. Epub 2012 Dec 2. Bioorg Med Chem Lett. 2013. PMID: 23260346 Free PMC article.
116 results